Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of children exposed in utero to retosiban treatment
2014-000499-24Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of retosiban in Preterm labor (PTL) and preterm birth (2 arms), sponsored by GSK. Primary endpoint: Morbidity and mortality endpoints. Started Nov 2014; status: completed.
02
Drugs
retosiban
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on 2014-000499-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000499-24.